A research team led by the A*STAR Genome Institute of Singapore (A*STAR GIS) have developed a method to accurately and ...

Analysts expect PDS Biotechnology to report an earnings per share (EPS) of $-0.20. PDS Biotechnology bulls will hope to hear ...

Pds Biotechnology (($PDSB)) has held its Q3 earnings call. Read on for the main highlights of the call. The recent earnings call of PDS ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial ...

ValGenesis has a two-decade history of innovation in life sciences technology. In 2005, the company introduced the world's first digital validation lifecycle management system-a breakthrough that ...

Ecuadorian scientists are developing a biotechnological strategy to stop banana wilt by genetically editing the causative ...

UD chemical engineer wins the AIChE Langer Prize for efforts to harness biology to manage plastic waste sustainably ...

PDS Biotechnology Corporation (NASDAQ: PDSB) Q3 2025 Earnings Call Transcript November 13, 2025 ...

Picture a world where most life-saving medicines are discovered not in the United States, but in Beijing and Shanghai. Imagine a time when the most advanced biotechnologies, therapies that cure ...

Puma Biotechnology has one approved drug, strong cash, and is developing alisertib with key ALISCA trial readouts in 1H 2026.

A global biotechnology company with roots in the Capital Region is expanding into Saratoga County with a new facility.

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 4 undervalued ...